Cite
APA Citation
Nishikawa, N., Shoji, T., Enomoto, T., Abe, M., Okamoto, A., Saito, T., Oishi, T., Nagase, S., Mori, M., Inokuchi, Y., Kamiura, S., & Sugiyama, T. (n.d.). 14 Phase II trial evaluating efficacy and safety of standard of care with or without bevacizumab in platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer. International journal of gynecological cancer, 30, A10–A11. http://access.bl.uk/ark:/81055/vdc_100144713484.0x00001b